Takaaki Ohtake

Nasushiobara, 3292763, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Young-onset hepatocellular carcinoma following double outlet right ventricle surgery without liver congestion: a case report with genetic analysis.

Young-onset hepatocellular carcinoma following double outlet right ventricle surgery without liver congestion: a case report with genetic analysis.

Journal: Clinical journal of gastroenterology
Published: July 31, 2025

Remarkable response to durvalumab and tremelimumab in a patient with hepatocellular carcinoma: a case report.

Remarkable response to durvalumab and tremelimumab in a patient with hepatocellular carcinoma: a case report.

Journal: Clinical journal of gastroenterology
Published: July 29, 2025

5-Fluorouracil-Related Lactic Acidosis in a Patient with Colon Cancer.

5-Fluorouracil-Related Lactic Acidosis in a Patient with Colon Cancer.

Journal: Internal medicine (Tokyo, Japan)
Published: June 26, 2025

Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Journal: PloS one
Published: December 21, 2023

Non-traumatic False Cyst of the Spleen: A Case Report and Review of the Literature.

Non-traumatic False Cyst of the Spleen: A Case Report and Review of the Literature.

Journal: Internal medicine (Tokyo, Japan)
Published: April 02, 2023

Cases of Rapid Hepatitis B Surface Antigen Reduction after COVID-19 Vaccination.

Cases of Rapid Hepatitis B Surface Antigen Reduction after COVID-19 Vaccination.

Journal: Internal medicine (Tokyo, Japan)
Published: October 19, 2022

Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths.

Iron chelator deferasirox inhibits NF-κB activity in hepatoma cells and changes sorafenib-induced programmed cell deaths.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 20, 2022

Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.

Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: July 19, 2020

Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosis.

Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 13, 2019

Identification of heterozygous p.Y150C and p.V274M mutations in the HJV gene in a Japanese patient with a mild phenotype of juvenile hemochromatosis: A case report.

Identification of heterozygous p.Y150C and p.V274M mutations in the HJV gene in a Japanese patient with a mild phenotype of juvenile hemochromatosis: A case report.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: March 10, 2019

Splicing variant of hepcidin mRNA.

Splicing variant of hepcidin mRNA.

Journal: Vitamins and hormones
Published: February 26, 2019

The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease.

The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease.

Journal: Journal of clinical medicine research
Published: January 30, 2018
Showing 1-12 of 31

Last Updated: 09/26/2026